Akebia Therapeutics, Inc. revenue breakdown overview

Akebia Therapeutics, Inc. revenue for the last year amounted to 160.18 M USD, the most of which — 160.18 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 194.62 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Akebia Therapeutics, Inc. 160.18 M USD, and the year before that — 194.62 M USD.